Mechanisms of Enhanced Resistance of Mycobacterium Bovis BCG-treated Mice to Ectromelia Virus Infection

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1983 Nov 1

PMID 6315580

Citations 12

Authors

T Sakuma

T Suenaga

I Yoshida

M Azuma

Affiliations

Soon will be listed here.

Abstract

The mechanism of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection was investigated by determining the effect of splenectomy, antithymocyte serum, and antimacrophage serum on resistance. It was greatly reduced by these treatments, not only in normal mice, but also in mice treated with live or heat-inactivated BCG. Production of circulating interferon by ectromelia virus and Newcastle disease virus was augmented in BCG-treated mice and was markedly depressed by splenectomy and antithymocyte and antimacrophage serum treatments in both BCG-treated and normal mice. Carbon clearance activity was activated in BCG-treated mice, but splenectomy did not influence phagocytic activity. These results suggest that augmented interferon production in the spleens of BCG-treated mice plays a major role in enhanced resistance. Other possible mechanisms are discussed.

Citing Articles

Current Understanding of Bacillus Calmette-Guérin-Mediated Trained Immunity and Its Perspectives for Controlling Intracellular Infections.

de Araujo A, Mambelli F, Sanches R, Marinho F, Oliveira S Pathogens. 2023; 12(12).

PMID: 38133271 PMC: 10745672. DOI: 10.3390/pathogens12121386.

BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.

Gong W, Mao Y, Li Y, Qi Y Int Immunopharmacol. 2022; 108:108870.

PMID: 35597119 PMC: 9113676. DOI: 10.1016/j.intimp.2022.108870.

BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander?.

Koneru G, El-Saber Batiha G, Algammal A, Mabrok M, Magdy S, Sayed S Infect Drug Resist. 2021; 14:1169-1184.

PMID: 33790587 PMC: 8001200. DOI: 10.2147/IDR.S300162.

Local Pulmonary Immunological Biomarkers in Tuberculosis.

Morrison H, McShane H Front Immunol. 2021; 12:640916.

PMID: 33746984 PMC: 7973084. DOI: 10.3389/fimmu.2021.640916.

The double-sided effects of Mycobacterium Bovis bacillus Calmette-Guérin vaccine.

Li J, Zhan L, Qin C NPJ Vaccines. 2021; 6(1):14.

PMID: 33495451 PMC: 7835355. DOI: 10.1038/s41541-020-00278-0.

References

Welsh R . Natural cell-mediated immunity during viral infections. Curr Top Microbiol Immunol. 1981; 92:83-106. DOI: 10.1007/978-3-642-68069-4_6. View

GRESSER I, Tovey M, Maury C, Bandu M . Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med. 1976; 144(5):1316-23. PMC: 2190450. DOI: 10.1084/jem.144.5.1316. View

Zisman B, Hirsch M, Allison A . Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol. 1970; 104(5):1155-9. View

Kirchner H, Engler H, Zawatzky R, Schindler L . Role of natural killer cells and of interferon in natural resistance against virus infections. Adv Exp Med Biol. 1982; 155:785-97. DOI: 10.1007/978-1-4684-4394-3_86. View

Allison A, Law L . Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med. 1968; 127(1):207-12. DOI: 10.3181/00379727-127-32657. View

GRESSER I, Tovey M, Bandu M, Maury C, Brouty-Boye D . Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med. 1976; 144(5):1305-15. PMC: 2190462. DOI: 10.1084/jem.144.5.1305. View

Larson C, USHIJIMA R, Karim R, Baker M, Baker R . Herpesvirus hominis type 2 infections in rabbits: effect of prior immunization with attenuated Mycobacterium bovis (BCG) cells. Infect Immun. 1972; 6(4):465-8. PMC: 422560. DOI: 10.1128/iai.6.4.465-468.1972. View

FRUITSTONE M, Michaels B, Rudloff D, Sigel M . Role of the spleen in interferon production in mice. Proc Soc Exp Biol Med. 1966; 122(4):1008-11. DOI: 10.3181/00379727-122-31311. View

GORHE D . Inhibition of multiplication of foot and mouth disease virus in adult mice pretreated with Freund's complete adjuvant. Nature. 1967; 216(5121):1242-4. DOI: 10.1038/2161242a0. View

10.

Hirsch M, Murphy F . Effects of anti-lymphoid sera on viral infections. Lancet. 1968; 2(7558):37-40. DOI: 10.1016/s0140-6736(68)92904-8. View

11.

Zisman B, Wheelock E, Allison A . Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol. 1971; 107(1):236-43. View

12.

Hirsch M, Nahmias A, Murphy F, Kramer J . Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness. J Exp Med. 1968; 128(1):121-32. PMC: 2138509. DOI: 10.1084/jem.128.1.121. View

13.

Riviere Y, GRESSER I, GUILLON J, Tovey M . Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc Natl Acad Sci U S A. 1977; 74(5):2135-9. PMC: 431090. DOI: 10.1073/pnas.74.5.2135. View

14.

Hirsch M, Zisman B, Allison A . Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol. 1970; 104(5):1160-5. View

15.

Lodmell D, Ewalt L . Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection. Infect Immun. 1978; 22(3):740-5. PMC: 422222. DOI: 10.1128/iai.22.3.740-745.1978. View

16.

Gresser J, MOREL-MAROGER L, Verroust P, Riviere Y, GUILLON J . Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A. 1978; 75(7):3413-6. PMC: 392787. DOI: 10.1073/pnas.75.7.3413. View

17.

Bang F, Warwick A . MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY. Proc Natl Acad Sci U S A. 1960; 46(8):1065-75. PMC: 223001. DOI: 10.1073/pnas.46.8.1065. View

18.

Lodmell D, Ewalt L . Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine. Infect Immun. 1978; 19(1):225-30. PMC: 414071. DOI: 10.1128/iai.19.1.225-230.1978. View

19.

Pusateri A, Ewalt L, Lodmell D . Nonspecific inhibition of encephalomyocarditis virus replication by a type II interferon released from unstimulated cells of Mycobacterium tuberculosis-sensitized mice. J Immunol. 1980; 124(3):1277-83. View

20.

SUBRAHMANYAN T, Mims C . Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice. Br J Exp Pathol. 1966; 47(2):168-76. PMC: 2094566. View